PATENT CLAIM ANALYSIS

Application Number: 15893861
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "682000"]

Abstract:
The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.

Claim (Index 107):
A therapeutic composition comprising magnesium glycinate, wherein the composition comprises about 20 mg to about 1200 mg magnesium, the composition is formulated for oral administration and the composition comprises an enteric coating.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 88.0
- Lexical Diversity: 1.85714
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15477325', '15155366', '12422012', '13445771', '13856084']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7489125172379882
- 35 USC 102 Novelty (BERT): 0.5705036759743853
- Combined Prediction Score: 0.7310716331116279
- Mean Citation Score: 413.804244
- Max Citation Score: 436.84155
- Similarity Product: 434.0425661816865

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test